Table 1 Clinical characteristics MIBC patients—discovery cohort.
From: Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Patient | Gender | Age | Disease stage | Progression (0: no, 1: yes) | Days till progression |
|---|---|---|---|---|---|
1 | M | 45 | pT4bN2Mx | 1 | 133 |
2 | M | 51 | pT4N0Mx R1 | 1 | 314 |
3 | F | 74 | pT3bN0Mx | 0 | Â |
4 | M | 62 | pT3bNxMx | 0 | Â |
5 | M | 60 | pT4aN0Mx | 0 | Â |
6 | F | 63 | pT3aN2M1 | 1 | 193 |
7 | F | 61 | pT3N0Mx | 1 | 146 |
8 | M | 76 | pT3bN0Mx | 0 | Â |
9 | M | 76 | pT3bG3N0Mx | 0 | Â |
10 | M | 65 | pT3N0Mx | 0 | Â |
11 | M | 62 | pT3bN0Mx | 0 | Â |
12 | M | 72 | pT3aN3Mx | 1 | 104 |
